Working 55 hours or more per week associated with higher risk of stroke
the ONA take:
Working 55 hours or more per week is associated with a 33% increased risk for stroke and a 133% increased risk for developing coronary heart disease compared with working a standard 40-hour week, a large study published in the journal The Lancet has shown.
For the systematic review, researchers from University College London in London, UK, sought to examine the effects of longer workup hours on cardiovascular disease up to mid-2014. The analysis included 603,838 people from 3 continents that participated in 25 studies.
Researchers found that people who worked 55 hours or more per week had a 13% increased of incident coronary heart disease compared with those working 35 to 40 hours per week. When researchers only included 528,908 from 17 studies, there was 1.3 times greater risk of stroke in people working 55 or more hours a week compared with those working standard hours.
"Health professionals should be aware that working long hours is associated with a significantly increased risk of stroke, and perhaps also coronary heart disease," Mika Kivimäki, Professor of Epidemiology at University College London, UK, said.
Working 55 hours or more per week is associated with a 33% increased risk for stroke and a 133% increased risk for developing coronary heart disease .
- FDA Grants Approval to Bevacizumab-awwb as First Biosimilar for Anticancer Therapy
- Efficacy of Octreotide LAR, Lanreotide in Management of Carcinoid Tumors
- Multivitamin Use May Reduce Risk of Chemo-Induced Neuropathy
- Overall Survival in Advanced Melanoma Improved With Nivolumab, Ipilimumab Combination
- Adjuvant Durvalumab Therapy May Prolong Progression-free Survival in NSCLC
- Invisible Burdens: The Complex Needs of Caregivers of Patients With Brain Cancer
- Cannabis Reduces Response Rate to Immunotherapy for Cancer
- Perioperative Blockade of Pathways May Improve Outcomes in Breast Cancer
- Zika Virus Preferentially Targets Glioblastoma Stem Cells
- Daratumumab Infusion-Related Reactions Managed by Pre/Postinfusion Medications
- Lorazepam Plus Haloperidol Improves Agitation in Cancer-Related Delirium
- Cost of Care Significantly Increased With Carcinoid Syndrome in NETs
- Treating Intractable Hiccups in Advanced Cancer, Palliative Care Setting
- Severe Mental Illness May Worsen Breast Cancer Survival Outcomes
- Imaging Management of Breast Density, a Controversial Risk Factor for Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|